Tenet Healthcare Non-GAAP EPS of $6.12 beats by $1.86, revenue of $5.62B beats by $180M
Tenet Healthcare's (THC) Q2 results exceeded expectations, with a non-GAAP EPS of $6.12, surpassing estimates by $1.86, and revenue of $5.62B, exceeding expectations by $180M, marking a surprise.
We considered entering based on strong fundamental momentum from positive earnings news and an upward revision of guidance. Following the earnings announcement on July 24, the stock price movement and the maintenance of UBS's rating have continued to provide positive news flow, making this a point where we can expect an upward trend.
The upward momentum due to positive earnings news is expected to continue. If the target price of $215.0 is reached, I will take profits. Conversely, if it falls below the support level of 195 and the stop-loss price of $190.0 is breached, I will consider the risk of further declines and cut my losses. Until the resistance level of 205 is broken, there is a possibility of increased volatility, so I will respond based on these conditions.
Past similar success cases include Bausch Health (BHC, return 28.7%, EPS and revenue surprise) recorded on 2026-07-31, the same date for this stock Tenet Healthcare (THC, return 27.0%, EPS $6.12 and revenue $5.62B surprise), and Texas (WHD, return 18.5%, EPS and revenue surprise).
We approached with a conservative forecast return of 3.2%, but the actual result recorded a high return of 27.0%, resulting in an OVERHIT designation. The surprise in Q2 non-GAAP EPS and revenue, along with UBS maintaining its rating and raising its guidance, confirmed that these fundamental positives acted as strong upward momentum for the stock price. However, there is a lingering disappointment that the full extent of the increase was not reflected due to concerns over potential volatility before breaking through the resistance level.
For stocks that have shown strong earnings surprises and upward guidance, rather than setting overly conservative price targets due to volatility concerns near initial resistance levels, we will reflect a strategic adjustment in the next trade by believing in the sustainability of momentum and flexibly extending the profit-taking line.